India to United States: Naproxen Export Trade Route

The India to United States Naproxen corridor is one of India's established pharmaceutical export routes, with 606 shipments documented worth a combined $38.2M USD. The route is dominated by AMNEAL PHARMACEUTICALS PRIVATE LIMITED, which alone accounts for roughly 24% of all export value, reflecting the consolidated nature of India's naproxen manufacturing sector.

Across 19 active suppliers, the average shipment value stands at $63.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 85% of all shipments, consistent with naproxen's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 17 days port-to-port. The route has recorded an annual growth rate of 19.3%, placing it at rank #12 among India's top naproxen export destinations globally.

On the import side, key buyers of Indian naproxen in United States include AMNEAL PHARMACEUTICALS, LLC (KY), DR REDDYS LABORATORIES INC, GLENMARK PHARMACEUTICALS INC., USA and 57 others. AMNEAL PHARMACEUTICALS, LLC (KY) is the single largest importer with 55 shipments valued at $5.3M USD.

India's naproxen exports to United States are driven primarily by a handful of large-scale manufacturers. AMNEAL PHARMACEUTICALS PRIVATE LIMITED with 86 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 19 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — AMNEAL PHARMACEUTICALS PRIVATE LIMITED, GLENMARK PHARMACEUTICALS LIMITED, GRANULES INDIA LIMITED — together account for 57% of total trade value on this route. The average shipment value of $63.1K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as naproxen tablets usp 500 mg ndc 65162-0190-50 fda product code 62 g c a 49 anda# 75927 unit pack 500 and naproxen and esomeprazole mg dr tabs 500/20mg 60 s 6024 x 60 s packs= 361440 nos, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, AMNEAL PHARMACEUTICALS, LLC (KY) is the largest importer with 55 shipments worth $5.3M USD — representing 14% of all naproxen imports from India on this route. A total of 60 buyers are active on this corridor.